Clinical Trials on Light-Chain Amyloidosis
Total 0 results
Nothing found
Sponsors and Collaborators
- Kawin Technology Share-holding Co., Ltd.
- Montreal Neurological Institute and Hospital
- MingSight Pharmaceuticals Pty Limited
- CTC Bio, Inc.
- New York State Health Foundation
- Ionis Pharmaceuticals
- Wushan County People's Hospital
- Northern California Melanoma Center
- Rex Bionics Plc
- Marilia Medicine School
- The Third Hospital of Changsha
- Zahra Rabbani Khah
- Mitchell Scheiman
- Honda R and D Americas, Inc.
- European Network For Smoking and Tobacco Prevention
- Jeffrey Rudolph
- Jeffrey W. Clark, MD
- Health Parametrics Inc.
- Medtronic Atrial Fibrillation Solutions
- John Granton
- View Full List
Medical Conditions
- Advanced Esophageal Cancers
- H.Pylori Infection
- Primary Generalized Dystonia
- Pregnancy-Related Condition, Unspecified
- Locally Advanced NSCLC
- HDT-AHCT
- Ascaris Suum
- Metastatic Spine Lesions
- LSIL
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Periferal Arterial Occlusive Disease, PAOD
- ACTH-Secreting Pituitary Adenoma
- Renal Cancer Metastatic
- Brain MRI
- Liver Hemangioma
- Fasting, Diet, Chemotherapy, Toxicity
- Waldenstrom's Macroglobulinemia Recurrent
- Hyperthyroidism, Autoimmune
- Pancreatic Neoplasms
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- View Full List
Drug Interventions
- Nimotuzumab
- AZD7798
- Levobupivacaine, clonidine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Ombrabulin (AVE8062)
- Fludarabine
- Hydroxychloroquine
- CKD-519
- Levcromakalim
- Bendamustine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Postoperative analgesia management
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- ESK981
- Rifaximin
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Toripalimab plus Anlotinib
- Pentostatin
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 200 µg doxorubicin-containing MNA
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Djibouti
- Contract Research Organizations in France
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Portugal
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Singapore
- Contract Research Organizations in Venezuela
- Contract Research Organizations in Zimbabwe
- CRO list by country